Close Menu

Pathway Genomics' Insight test will be on the shelves of about 6,000 Walgreens, reports the Washington Post. This "boldest move yet to bring the power of modern molecular medicine to the mass market" may also me "irresponsible" as it "could give many buyers a dangerous false sense of security or, conversely, needlessly alarm them," the Post says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.